CompletedNot Applicable

Improvement of Fatigue in Unstable Shoulder Through a Therapeutic Exercise Program in Physiotherapy

Spain108 participantsStarted 2023-03-15

Plain-language summary

Background: Glenohumeral instability is a highly prevalent pathology; however, there is great controversy in its definition. Traditionally, structural problems such as labral injury or bone loss in the glenoid cavity were considered the main causes; but recently, it has been seen that motor control plays a very relevant role. This means that currently, there is a disparity of action protocols and the treatment of this pathology is a great challenge. Aim: The primary aim of this study is to evaluate the effectiveness of a supervised multicomponent therapeutic exercise program in reducing multivariable fatigue in patients with instability of the glenohumeral joint. Methods: A single-blind randomized controlled trial will be carried out, in which 108 adult patients who have suffered at least one episode of glenohumeral instability in the last year will be recruited, who will be randomized to the intervention group, which will carry out a multicomponent therapeutic exercise program supervised by physiotherapists (MoveUS Program); or to the control group, which will receive the usual care. All subjects will be evaluated at baseline, mid-treatment and at the end. In these evaluations, range of movement, maximum peak of isometric force, kinematic, physiological and psychometric fatigue, return to activity, motor control and number of recurrences will be assessed; as well as the quality of life measured through the Western Ontario Shoulder Instability Index, which will be the main outcome variable. A multivariate analysis will be performed through a statistical program. Discussion: This study aims to determine if therapeutic exercise supervised by physiotherapists is capable of reducing multivariable fatigue, reducing the number of recurrences and improving quality of life; to be able to implement it in the future in public and private centers.

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Having suffered at least one episode of glenohumeral instability in the last year. * Age between 18 and 64 years. * Have signed the informed consent. * Score equal to or less than 6 on the Instability Severity Index Score. Exclusion Criteria: * Ethical or cultural barriers. * Lack of command of Spanish language. * Underlying diseases or concomitant treatments that may affect exercise capacity. * Participation in other clinical trials. * Score equal to or greater than 1800 on the Western Ontario Shoulder Instability Index.

What they're measuring

Quality of life (WOSI)

Timeframe: 12 weeks

Trial details

NCT IDNCT05443295

SponsorUniversity of Malaga

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-09